Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex
McNamara, Molly C., Hosios, Aaron M., Torrence, Margaret E., Zhao, Ting, Fraser, Cameron, Wilkinson, Meghan, Kwiatkowski, David J., Henske, Elizabeth P., Wu, Chin-Lee, Sarosiek, Kristopher A., Valvezan, Alexander J., Manning, Brendan D.
Published in iScience (18.11.2022)
Published in iScience (18.11.2022)
Get full text
Journal Article
BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance
Ferretti, Roberta, Bhutkar, Arjun, McNamara, Molly C, Lees, Jacqueline A
Published in Genes & development (01.01.2016)
Published in Genes & development (01.01.2016)
Get full text
Journal Article
mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability
Valvezan, Alexander J., Turner, Marc, Belaid, Amine, Lam, Hilaire C., Miller, Spencer K., McNamara, Molly C., Baglini, Christian, Housden, Benjamin E., Perrimon, Norbert, Kwiatkowski, David J., Asara, John M., Henske, Elizabeth P., Manning, Brendan D.
Published in Cancer cell (13.11.2017)
Published in Cancer cell (13.11.2017)
Get full text
Journal Article
IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex
Valvezan, Alexander J, McNamara, Molly C, Miller, Spencer K, Torrence, Margaret E, Asara, John M, Henske, Elizabeth P, Manning, Brendan D
Published in JCI insight (09.04.2020)
Published in JCI insight (09.04.2020)
Get full text
Journal Article